ELAVL1 and triple-negative breast carcinoma: We then manipulated the HuR expression level in a highly metastatic human triple-negative breast cancer (TNBC) cell line, MDA-MB-231, using shRNA and CRISPR/CAS9 approaches to determine whether HuR inhibition would affect cell proliferation and invasion.